Assembly Biosciences Inc. (ASMB)
14.60
-0.29 (-1.95%)
At close: Jan 14, 2025, 3:59 PM
14.40
-1.37%
Pre-market Jan 15, 2025, 08:44 AM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Revenue | 7.16M | n/a | 6.25M | 79.11M | 15.96M | 14.80M | 9.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 48.90M | 498.00K | 466.00K | 101.34K | 85.32K | 72.74M | 44.23M | 80.25K | 64.99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | -41.74M | -498.00K | 5.79M | 79.00M | 15.88M | -57.94M | -35.21M | -80.25K | -64.99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -64.65M | -94.11M | -132.69M | -64.78M | -102.71M | -92.73M | -52.23M | -45.28M | -29.66M | -23.96M | -19.60M | -24.86M | -34.00M | -4.77M | -3.34M | -7.16M |
| Interest Income | 3.45M | 1.02M | 302.00K | 2.62M | 4.30M | 3.08M | 983.21K | 1.54M | 1.23M | 167.65K | 201.02K | 65.07K | 76.33K | 5.73K | 140.00 | 13.09K |
| Pretax Income | -61.20M | -93.09M | -132.39M | -62.15M | -98.41M | -89.65M | -51.86M | -44.88M | -28.45M | -23.79M | -19.40M | -24.79M | -34.34B | -15,290.60B | n/a | n/a |
| Net Income | -61.23M | -92.07M | -129.85M | -59.53M | -97.63M | -90.75M | -42.81M | -44.26M | -28.45M | -23.79M | -19.40M | -24.79M | -34.34M | -15.29M | -4.54M | -8.79M |
| Selling & General & Admin | 22.91M | 24.13M | 28.78M | 37.06M | 32.92M | 34.80M | 17.02M | 12.19M | 11.30M | 13.24M | 4.58M | 5.34M | 8.72M | 2.92M | 397.24K | 1.19M |
| Research & Development | 48.90M | 69.98M | 68.52M | 106.82M | 85.76M | 72.74M | 44.23M | 33.09M | 18.36M | 10.72M | 15.03M | 19.51M | 25.28M | 1.85M | 2.94M | 5.98M |
| Other Expenses | n/a | n/a | 41.64M | n/a | 5.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 71.81M | 94.11M | 97.30M | 143.88M | 118.68M | 107.54M | 61.25M | 45.28M | 29.66M | 23.96M | 19.60M | 24.86M | 34.00M | 4.77M | 3.34M | 7.16M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 116.66K | 10.53M | 1.20M | 1.64M |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 71.81M | 94.11M | 97.30M | 143.88M | 118.68M | 107.54M | 61.25M | 45.28M | 29.66M | 23.96M | 19.60M | 24.86M | 34.00M | 4.77M | 3.34M | 7.16M |
| Income Tax | 33.00K | -1.02M | -2.53M | -2.62M | -774.00K | 1.10M | -9.05M | -617.67K | -1.20M | n/a | 201.02K | 65.07K | 342.66K | -10,524.40B | 1.20M | 1.62M |
| Shares Outstanding (Basic) | 4.58M | 4.03M | 46.54M | 39.68M | 35.08M | 22.80M | 17.75M | 17.23M | 15.70M | 7.00M | 3.88M | 2.55M | 1.92M | 123.98K | 89.01K | 84.34K |
| Shares Outstanding (Diluted) | 4.58M | 4.03M | 46.85M | 39.68M | 35.08M | 22.80M | 17.75M | 17.23M | 15.70M | 7.00M | 3.88M | 2.55M | 1.92M | 123.98K | 89.01K | 84.34K |
| EPS (Basic) | -13.38 | -22.82 | -2.79 | -1.5 | -2.78 | -3.98 | -2.41 | -2.57 | -1.81 | -3.4 | -5 | -9.74 | -17.86 | -123.33 | -51 | -104.17 |
| EPS (Diluted) | -13.38 | -22.82 | -2.77 | -1.5 | -2.78 | -3.98 | -2.41 | -2.57 | -1.81 | -3.4 | -5 | -9.74 | -17.86 | -123.33 | -51 | -104.17 |
| EBITDA | -64.20M | -92.59M | -91.93M | -64.78M | -102.71M | -92.73M | -52.01M | -44.80M | -29.59M | -23.95M | -19.40M | -24.79M | -46.72M | -13.23M | -3.33M | -7.16M |
| Depreciation & Amortization | 450.00K | 498.00K | 466.00K | 691.00K | 494.00K | 643.00K | 219.22K | 80.25K | 64.99K | 10.97K | 6.22K | 4.62K | 3.75K | 12.53K | 7.51K | 4.65K |